Kiwi start-up Kitea Health has experienced a successful start to 2025. 

In the last three months, Kitea has secured a place in the FDA fast track programme and they’ve completed a world first - implanting one of their sensors into the brain of a child. 

The company has also revealed it's  $7 million and counting into a $10 million funding round.

Kitea Health co-founder Simon Malpas says their product went through 10 years of research before getting started.

"We're so pleased for Kitea to be in our clinical trials - and in Auckland City Hospital, treating Kiwis. It's just a fantastic position to be in." 

LISTEN ABOVE